Journal of Physiology-Paris

The Schwann cell at the neuromuscular junction
pp. 153-155(3)
Authors: Koenig J.; De La Porte S.; Chapron J.

Lipid peroxidation and changes in cytochrome c oxidase and xanthine oxidase activity in organophosphorus anticholinesterase induced myopathy
pp. 157-161(5)
Authors: Yang Z.P.; Dettbarn W.-D.

Regulation of gene expression by trans-synaptic activity: A role for the transcription factor NF-B
pp. 163-166(4)
Author: Gisiger V.

Development of the neuromuscular junction: Genetic analysis in mice
pp. 167-172(6)
Authors: Sanes J.R.; Apel E.D.; Burgess R.W.; Emerson R.B.; Feng G.; Gautam M.; Glass D.; Grady R.M.; Krejci E.; Lichtman J.W.; Lu J.T.; Massoulie J.; Miner J.H.; Moscoso L.M.; Nguyen Q.; Nichol M.; Noakes P.G.; Patton B.L.; Son Y.-J.; Yancopoulos G.D.; Zhou H.

Transcriptional pathways for synapse-specific, neuregulin-induced and electrical activity-dependent transcription
pp. 173-176(4)
Authors: Fromm L.; Burden S.J.

Targeting of acetylcholine receptor and 43 kDa rapsyn to the postsynaptic membrane in Torpedo marmorata electrocyte
pp. 177-181(5)
Authors: Bignami F.; Camus G.; Marchand S.; Bailly L.; Stetzkowski-Marden F.; Cartaud J.

Acetylcholinesterase: C-terminal domains, molecular forms and functional localization
pp. 183-190(8)
Authors: Massoulie J.; Anselmet A.; Bon S.; Krejci E.; Legay C.; Morel N.; Simon S.

Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica
pp. 191-193(3)
Authors: Kryger G.; Silman I.; Sussman J.L.

Targeting acetylcholinesterase molecules to the neuromuscular synapse
pp. 195-198(4)
Authors: Rotundo R.L.; Rossi S.G.; Peng H.B.

Imprinting of hippocampal metabolism of choline by its availability during gestation: Implications for cholinergic neurotransmission
pp. 199-203(5)
Authors: Blusztajn J.K.; Cermak J.M.; Holler T.; Jackson D.A.

TrkA antagonists decrease NGF-induced ChAT activity in vitro and modulate cholinergic synaptic number in vivo
pp. 205-208(4)
Authors: Debeir T.; Saragovi H.U.; Cuello A.C.

Nicotine modifies the activity of ventral tegmental area dopaminergic neurons and hippocampal GABAergic neurons
pp. 209-213(5)
Authors: Fisher J.L.; Pidoplichko V.I.; Dani J.A.

The hypothesis of an ambient level of acetylcholine in the central nervous system
pp. 215-220(6)
Author: Descarries L.

The role of neuronal nicotinic acetylcholine receptors in antinociception: Effects of ABT-594
pp. 221-224(4)
Authors: Decker M.W.; Curzon P.; Holladay M.W.; Nikkel A.L.; Bitner R.S.; Bannon A.W.; Donnelly-Roberts D.L.; Puttfarcken P.S.; Kuntzweiler T.A.; Briggs C.A.; Williams M.; Arneric S.P.

Neural substrate of nicotine addiction as defined by functional brain maps of gene expression
pp. 225-228(4)
Authors: Pich E.M.; Chiamulera C.; Tessari M.

Is dopamine important in nicotine dependence?
pp. 229-233(5)
Author: Shoaib M.

Brain choline has a typical precursor profile
pp. 235-239(5)
Author: Loffelholz K.

Positive effects of allosteric modulators on the binding properties and the function of muscarinic acetylcholine receptors
pp. 241-243(3)
Authors: Tucek S.; Jakubik J.; Dolezal V.; El-Fakahany E.E.

On the transcriptional regulation of neuronal nA ChR genes
pp. 245-248(4)
Authors: Matter J.-M.; Matter-Sadzinski L.; Roztocil T.; Hernandez M.-C.; Couturier S.; Ong M.-T.; Ballivet M.

Position effect variegations and brain-specific silencing in transgenic mice overexpressing human acetylcholinesterase variants
pp. 249-255(7)
Authors: Sternfeld M.; Patrick J.D.; Soreq H.

Muscarinic acetylcholine receptors activate the acetylcholinesterase gene promoter
pp. 257-264(8)
Authors: Nitsch R.M.; Rossner S.; Albrecht C.; Mayhaus M.; Enderich J.; Schliebs R.; Wegner M.; Arendt T.; von der Kammer H.

Structure-function analysis of muscarinic acetylcholine receptors
pp. 265-268(4)
Authors: Kostenis E.; Zeng F.-Y.; Wess J.

Scanning mutagenesis of transmembrane domain 3 of the M1 muscarinic acetylcholine receptor
pp. 269-274(6)
Authors: Hulme E.C.; Lu Z.-L.

Molecular mechanisms for the regulation of the expression and function of muscarinic acetylcholine receptors
pp. 275-278(4)
Authors: Hamilton S.E.; Schlador M.L.; McKinnon L.A.; Chmelar R.S.; Nathanson N.M.

Role of neurotrophic factors in motoneuron development
pp. 279-281(3)
Authors: Henderson C.E.; Yamamoto Y.; Livet J.; Arce V.; Garces A.; deLapeyriere O.

Cholinergic foundations of Alzheimer's disease therapy
pp. 283-287(5)
Author: Giacobini E.

The role of A42 in Alzheimer's disease
pp. 289-292(4)
Author: Younkin S.G.

Some cholinergic themes related to Alzheimer's disease: Synaptology of the nucleus basalis, location of m2 receptors, interactions with amyloid metabolism, and perturbations of cortical plasticity
pp. 293-298(6)
Author: Mesulam M.-M.

The effects of the acetylcholinesterase inhibitor ENA713 and the M1 agonist AF150(S) on apolipoprotein E deficient mice
pp. 299-303(5)
Authors: Chapman S.; Fisher A.; Weinstock M.; Brandies R.; Shohami E.; Michaelson D.M.

Neuromuscular responses to pyridostigmine bromide in organotypic spinal cord-muscle culture
pp. 305-308(4)
Authors: Drake-Baumann R.; Seil F.J.; Spencer P.S.

Contribution of nicotinic receptors to the function of synapses in the central nervous system: The action of choline as a selective agonist of 7 receptors
pp. 309-316(8)
Authors: Albuquerque E.X.; Pereira E.F.R.; Braga M.F.M.; Alkondon M.

Chronic neurobehavioral and central and autonomic nervous system effects of Tokyo subway sarin poisoning
pp. 317-323(7)
Authors: Yokoyama K.; Araki S.; Murata K.; Nishikitani M.; Okumura T.; Ishimatsu S.; Takasu N.

Long term health effects of low dose exposure to nerve agent
pp. 325-328(4)
Author: Moore D.H.

Cholinergic excitation induces activity-dependent electrophysiological and transcriptional responses in hippocampal slices
pp. 329-335(7)
Authors: Friedman A.; Kaufer D.; Pavlovsky L.; Soreq H.